Josh Snyder

492 total citations
6 papers, 189 citations indexed

About

Josh Snyder is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Josh Snyder has authored 6 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Genetics. Recurrent topics in Josh Snyder's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cell Adhesion Molecules Research (2 papers). Josh Snyder is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cell Adhesion Molecules Research (2 papers). Josh Snyder collaborates with scholars based in United States and Japan. Josh Snyder's co-authors include Brian A. Mendelsohn, Julien Dugal‐Tessier, Zili An, David R. Stover, Héctor Aviña, Fernando Doñate, Karen Morrison, Ingrid B.J. Joseph, Peng Yang and Alla Verlinsky and has published in prestigious journals such as Cancer Research, Bioconjugate Chemistry and Molecular Cancer Therapeutics.

In The Last Decade

Josh Snyder

5 papers receiving 184 citations

Peers

Josh Snyder

ONCOL

RNMI

MB

SURGE

IMMUN

John Meekin United States

Verónica Robles United States

Brigitte Demers France

Lisa H. Lam United States

Sung-Ju Moon United States

Andy Futreal United States

Spencer H. Shao United States

Joseph Kauer Germany

Susana Bezares Spain

Dingwei Ye China

John Meekin United States

Josh Snyder

139 ×1.1

ONCOL

87 ×1.1

RNMI

37 ×0.6

MB

14 ×0.3

SURGE

21 ×1.2

IMMUN

Citations per year, relative to Josh Snyder Josh Snyder (= 1×) peers John Meekin

Countries citing papers authored by Josh Snyder

Since Specialization

Citations

This map shows the geographic impact of Josh Snyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh Snyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh Snyder more than expected).

Fields of papers citing papers by Josh Snyder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josh Snyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh Snyder. The network helps show where Josh Snyder may publish in the future.

Co-authorship network of co-authors of Josh Snyder

This figure shows the co-authorship network connecting the top 25 collaborators of Josh Snyder. A scholar is included among the top collaborators of Josh Snyder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josh Snyder. Josh Snyder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Snyder, Josh, et al.. (2018). Metabolism of an Oxime-Linked Antibody Drug Conjugate, AGS62P1, and Characterization of Its Identified Metabolite. Molecular Pharmaceutics. 15(6). 2384–2390. 27 indexed citations

2.

Zhao, Hui, Sathish Kumar Ganesan, Karen Morrison, et al.. (2017). Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia. Molecular Cancer Therapeutics. 16(9). 1877–1886. 47 indexed citations

3.

Mendelsohn, Brian A., et al.. (2017). Investigation of Hydrophilic Auristatin Derivatives for Use in Antibody Drug Conjugates. Bioconjugate Chemistry. 28(2). 371–381. 34 indexed citations

4.

Morrison, Kendall, Pia M. Challita-Eid, Arthur Raitano, et al.. (2016). Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6 , a New Urothelial Cancer Biomarker. Molecular Cancer Therapeutics. 15(6). 1301–1310. 55 indexed citations

5.

Campbell, Dean O., Akihiro Noda, Alla Verlinsky, et al.. (2016). Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys. Molecular Imaging and Biology. 18(5). 768–775. 25 indexed citations

6.

Zhao, Hui, Sathish Kumar Ganesan, Zhilan Zeng, et al.. (2016). Abstract 3853: Potential mechanisms for thrombocytopenia and neutropenia induced by antibody-drug conjugates. Cancer Research. 76(14_Supplement). 3853–3853. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact